These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23283463)

  • 1. Comparison of two rapid tests for anti-phenolic glycolipid-I serology in Brazil and Nepal.
    Stefani MM; Grassi AB; Sampaio LH; Sousa AL; Costa MB; Scheelbeek P; Neupane KD; Hagge DA; Macdonald M; Cho SN; Oskam L; Bührer-Sékula S
    Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():124-31. PubMed ID: 23283463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a rapid serological test for leprosy classification using human serum albumin as the antigen carrier.
    Moura RS; Penna GO; Fujiwara T; Pontes MA; Cruz R; Gonçalves Hde S; Penna ML; Cardoso LP; Stefani MM; Bührer-Sékula S
    J Immunol Methods; 2014 Oct; 412():35-41. PubMed ID: 24983877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ML flow test as a point of care test for leprosy control programmes: potential effects on classification of leprosy patients.
    Bührer-Sékula S; Visschedijk J; Grossi MA; Dhakal KP; Namadi AU; Klatser PR; Oskam L
    Lepr Rev; 2007 Mar; 78(1):70-9. PubMed ID: 17518099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroreactivity to new Mycobacterium leprae protein antigens in different leprosy-endemic regions in Brazil.
    Hungria EM; Oliveira RM; Souza AL; Costa MB; Souza VN; Silva EA; Moreno FR; Nogueira ME; Costa MR; Silva SM; Bührer-Sékula S; Reed SG; Duthie MS; Stefani MM
    Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():104-11. PubMed ID: 23283461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.
    Richardus RA; van der Zwet K; van Hooij A; Wilson L; Oskam L; Faber R; van den Eeden SJF; Pahan D; Alam K; Richardus JH; Geluk A
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006083. PubMed ID: 29228004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The result patterns of ML Flow and ELISA (PGL-I) serologic tests in leprosy-endemic and non-endemic areas.
    Silva RC; Lyon S; Araos R; Lyon AC; Grossi MA; Lyon SH; Penido RA; Bührer-Sékula S; Antunes CM
    Rev Soc Bras Med Trop; 2008; 41 Suppl 2():19-22. PubMed ID: 19618070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific antigen serologic tests in leprosy: implications for epidemiological surveillance of leprosy cases and household contacts.
    Carvalho APM; Coelho ADCO; Correa-Oliveira R; Lana FCF
    Mem Inst Oswaldo Cruz; 2017 Sep; 112(9):609-616. PubMed ID: 28902286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgM immunoglobulins reacting with the phenolic glycolipid-1 antigen from Mycobacterium leprae in sera of leprosy patients and their contacts.
    Saad MH; Medeiros MA; Gallo ME; Gontijo PP; Fonseca LS
    Mem Inst Oswaldo Cruz; 1990; 85(2):191-4. PubMed ID: 2087157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low predictive value of PGL-I serology for the early diagnosis of leprosy in family contacts: results of a 10-year prospective field study in French Polynesia.
    Chanteau S; Glaziou P; Plichart C; Luquiaud P; Plichart R; Faucher JF; Cartel JL
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):533-41. PubMed ID: 8151183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of leprosy by examination of household contacts, determination of serum anti-PGL-1 antibodies and consanguinity.
    Bazan-Furini R; Motta AC; Simão JC; Tarquínio DC; Marques W; Barbosa MH; Foss NT
    Mem Inst Oswaldo Cruz; 2011 Aug; 106(5):536-40. PubMed ID: 21894372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three immunological tests for leprosy diagnosis and detection of subclinical infection.
    Lobato J; Costa MP; Reis Ede M; Gonçalves MA; Spencer JS; Brennan PJ; Goulart LR; Goulart IM
    Lepr Rev; 2011 Dec; 82(4):389-401. PubMed ID: 22439279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with anti-phenolic glycolipid-I seropositivity among the household contacts of leprosy cases.
    Carvalho AP; da Conceição Oliveira Coelho Fabri A; Corrêa Oliveira R; Lana FC
    BMC Infect Dis; 2015 May; 15():219. PubMed ID: 26024906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil.
    Leturiondo AL; Noronha AB; do Nascimento MOO; Ferreira CO; Rodrigues FDC; Moraes MO; Talhari C
    BMC Infect Dis; 2019 Jan; 19(1):22. PubMed ID: 30616580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil.
    Hungria EM; Oliveira RM; Penna GO; Aderaldo LC; Pontes MA; Cruz R; Gonçalves HS; Penna ML; Kerr LR; Stefani MM; Bührer-Sékula S
    Infect Dis Poverty; 2016 Dec; 5(1):110. PubMed ID: 27919284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia.
    Desforges S; Bobin P; Brethes B; Huerre M; Moreau JP; Bach MA
    Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):794-800. PubMed ID: 2681462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the ML-Flow test as a tool in classifying and treating leprosy.
    Contin LA; Alves CJ; Fogagnolo L; Nassif PW; Barreto JA; Lauris JR; Nogueira ME
    An Bras Dermatol; 2011; 86(1):91-5. PubMed ID: 21437528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
    Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leprosy serology using PGL-I: a systematic review.
    Moura RS; Calado KL; Oliveira ML; Bührer-Sékula S
    Rev Soc Bras Med Trop; 2008; 41 Suppl 2():11-8. PubMed ID: 19618069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Mycobacterium Leprae-specific cellular and serological tests for the differential diagnosis of leprosy from confounding dermatoses.
    Freitas AA; Hungria EM; Costa MB; Sousa AL; Castilho ML; Gonçalves HS; Pontes MA; Duthie MS; Stefani MM
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):163-8. PubMed ID: 27506457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
    Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.